This infographic highlights the societal impact of vaccines, health systems financing models and their relevance to pharmacy-based vaccination (PBV), global PBV funding models, key barriers to PBV expansion, vaccine procurement strategies, and the direct/indirect economic impact of PBV.

Read document

With an analysis of the funding models, economic value, and broader societal benefits of pharmacy-based vaccination (PBV) services worldwide, this report explores challenges to sustainable financing of PBV and highlights both direct and indirect savings generated through PBV, including improved immunisation coverage and reduced burden of vaccine-preventable diseases. It offers a comprehensive set of recommendations to guide policymakers, healthcare leaders and pharmacy stakeholders seeking to strengthen vaccination services through integrated, sustainable models. An executive summary is also available here: https://lnkd.in/dy-DNhxm

Read publication

This infographic summarises the main findings and global trends on how legislative frameworks, stakeholder roles, and implementation strategies are shaping the future of pharmacy-based vaccination worldwide.

Read document

This report highlights significant policy developments, the expanding role of pharmacists in improving immunisation access, and key challenges such as regulatory restrictions and professional resistance. It showcases best practices from leading countries, offering insights into effective strategies for broader implementation of pharmacist-administered vaccination. It also serves as a resource for policymakers, healthcare professionals, and pharmacy organisations seeking to strengthen immunisation frameworks and integrate pharmacists into national vaccination strategies.

Read publication

Despite pharmacists’ role in providing accessible and evidence-based immunisation services to communities, their presence in advisory and decision-making roles on Vaccine Technical Committees, such as National Immunisation Technical Advisory Groups (NITAGs) and equivalent bodies, remains limited or underrepresented. This publication highlights the critical benefits of including pharmacists in these committees, explores the barriers preventing their involvement, identifies opportunities to enhance their representation, and outlines concrete strategies for engaging key stakeholders.

Read publication

This infographic outlines how seven countries finance and reimburse vaccination services in pharmacies. It also highlights the economic and healthcare benefits of pharmacist-led vaccination programmes, including cost-savings, improved coverage, and reduced strain on healthcare systems.

 

Read document

This infographic examines the role of pharmacists in delivering vaccinations. It provides insights into the scope of their practice, required training, and the overall impact of pharmacist-led vaccination efforts, highlighting successful models from seven countries: Australia, Canada, France, Ireland, Portugal, the UK, and the US.

Read document

This infographic outlines the progression toward implementing pharmacy-based vaccination in seven countries. It showcases the role of advocacy in policy change and the importance of collaboration among healthcare professionals, policymakers and the public for successful implementation.

Read document

This comprehensive advocacy brochure is derived from the FIP statement of policy on life-course vaccination and highlights key insights from our recent survey report, providing a clear and informative perspective on the importance of vaccinations through the life course.

Read document

In addition to providing a range of campaign materials, FIP’s 2024 World Pharmacy Week activities included a high-level policy symposium at UN City, Copenhagen, in collaboration with the World Health Organization Regional Office for Europe.
This poster was exhibited at the event, showcasing the contribution of the pharmacy profession to health to all visitors to the United Nations Building.

Read document

This brochure describes recent FIP resources presenting robust data and case studies on the current state of pharmacy-based vaccination (PBV) around the world. It highlights key findings and outlines the value of these resources for different stakeholders: FIP member organisations (MOs), policymakers, academic institutions, and external stakeholders. Specifically, it described two landmark reports and the FIP online atlas on PBV surveillance.

Read document

This statement discusses the importance of expanding vaccination schedules and strategies beyond infancy to ensure access to vaccines for all age groups, including adults and older persons. Pharmacists should be integrated into patient immunisation pathways and provide vaccines to special-risk groups, such as those with long-term conditions, pregnant individuals, healthcare professionals, underserved populations and caregivers.

Read Document

This self-assessment tool will help to identify strengths and areas for improvement in order to inform vaccination policy and planning efforts. It is an aid to help national ministries of health, regulators and national pharmacy organisations in assessing overall vaccination programmes and the state of legislation and regulations within their countries to facilitate vaccination and enhanced patient care through the pharmacy workforce and community pharmacies. The tool will help with vaccination planning and the utilisation of the pharmacy workforce in primary healthcare and community-based vaccination programmes.

While this tool is not exhaustive in content and has yet to be validated, it is based on the experiences of professional regulators in countries where pharmacy-led vaccination has been successfully introduced and regulated. The checklist is based on the objective to deploy the pharmacy workforce and utilise pharmacies to increase access to vaccination services.

This tool is primarily addressed to regulators and policy-makers to support them in developing strategies or enabling regulatory frameworks in countries where pharmacists and the pharmacy workforce have a limited role in vaccination strategies. It may also be useful as a review tool in countries where the pharmacy workforce already provides vaccine-related care but wishes to further expand or consolidate such roles.

This tool addresses the enabling legislation that is needed and makes reference to additional clarification of the limitations and parameters in the current regulations for future learning. Typically, new or changing legislation can be slow and difficult to draft and enact, but regulations can be made through a simpler and more agile process. Implementation might further require clarifying policies or standards which become the real “how to” guide for healthcare professionals from a public protection perspective.

FIP, its Professional Regulators Advisory Group and its member organisations are a resource for the drafting and development of supportive regulations, policies, standards of care and training programmes. Clearly, the desired goal is to create legislative change to establish enhanced patient care and patient access to vaccinations through pharmacy practice.

Read document

FIP organised in February and March 2022 a series of six regional roundtables with some of its member organisations and other key stakeholders from each region. These events were codeveloped and led by the FIP Forum of Professional Regulators and identified the drivers and barriers to the implementation of pharmacist-led vaccination in each region. In particular, they discussed the existing
challenges to interprofessional understanding, cooperation and task sharing in the area of vaccination.
Discussion topics included the regulatory authority granted to different healthcare professionals to prescribe and administer vaccines and the plans for the management of anti-COVID-19 vaccination in a post-pandemic scenario.

Read publication

Esta herramienta de autoevaluación ayudará a identificar los puntos fuertes y las áreas de mejora con el fin de informar sobre los esfuerzos de planificación de la pandemia antes de las olas actuales y futuras de COVID-19. Se trata de una ayuda para que los ministerios de sanidad y los organismos reguladores nacionales evalúen la preparación para la pandemia y el estado de la legislación y la normativa en sus países para facilitar la vacunación y las pruebas masivas y mejorar la atención a los pacientes a través de los farmacéuticos y las farmacias comunitarias.

Read publication

This statement addresses the global shortage of medicines and vaccines and the role pharmacists can have in supporting this global issue.

Read document

This resource offers practical guidance on implementing a vaccination service and sets out the roles and technical requirements for pharmacy-based vaccines-related services

Read publication

Aims to provide FIP member organisations with cases and arguments for achieving or expanding the roles of pharmacists in increasing vaccination coverage and uptake. (Access exclusive to FIP member organisations.)

This statement addresses the importance of access to medicines, medicine shortages and pharmacy in this context.

Read publication